Johnson & Johnson Pauses Late-Stage COVID-19 Vaccine Trial After Volunteer Becomes Sick
Pause is the second imposed by drugmakers racing to develop coronavirus vaccine; new study suggests COVID-19 patients remain vulnerable to reinfection/Articles similaires à Johnson & Johnson Pauses Late-Stage COVID-19 Vaccine Trial After Volunteer Becomes Sick
Germany Makes Johnson & Johnson COVID-19 Vaccine Available to All Adults
Health officials had limited vaccine to people over 60Actualités similaires
Johnson & Johnson COVID-19 Vaccine Under Further Scrutiny in US
CDC says it is looking into reports of possible new cases of severe side effects linked to one-dose vaccine, which health authorities have paused after six ...Actualités similaires
Johnson & Johnson Delays Rollout in Europe of its COVID-19 Vaccine / /
U.S. pharmaceutical giant cites links of vaccine to rare but potentially deadly blood clot for reason to delay European rolloutActualités similaires
Johnson & Johnson Delays European Rollout of COVID-19 Vaccine / /
U.S. pharmaceutical giant cites links of vaccine to rare but potentially deadly blood clot for reason to delay European rolloutActualités similaires
US Urges Pause in Use of Johnson & Johnson Single-Shot COVID-19 Vaccine
Centers for Disease Control and Prevention and Food and Drug Administration cite reports of blood clots among six women after receiving doseActualités similaires
Johnson & Johnson to Supply 400 Million COVID-19 Vaccine Doses to African Union
However, single-dose vaccine still must receive authorization from regulators in African countriesActualités similaires
The Infodemic: Johnson and Johnson Did Update on Volunteer Who Fell Ill During Vaccine Trial
Fake news about the coronavirus can do real harm. Polygraph.info is spotlighting fact-checks from other reliable sources here .Actualités similaires
US Advisers Endorse Single-shot COVID-19 Vaccine From Johnson & Johnson
The FDA panelists voted unanimously that the benefits of the vaccine outweighed the risks for adultsActualités similaires
Johnson & Johnson Pauses Late-Stage COVID-19 Vaccine Trial After Volunteer Becomes Sick
Pause is the second imposed by drugmakers racing to develop coronavirus vaccine; new study suggests COVID-19 patients remain vulnerable to reinfection/Actualités similaires
EU Contracts with Johnson & Johnson on Possible COVID-19 Vaccine
Announcement comes in light of fresh spike across Europe forcing countries to reintroduce previously relaxed COVID-19 restrictions, including shutdown of bars, ...Actualités similaires
US Drugmaker Begins Late-Stage Testing of Single-Dose COVID-19 Vaccine in US////
Vaccine from Johnson & Johnson becomes fourth to undergo large-scale testing under Trump administration's Operation Warp Speed initiativeActualités similaires
Johnson & Johnson Launches Final-Stage COVID-19 Vaccine Trial
Trump continues to push for accelerated approval despite safety concernsActualités similaires
US to Pay Johnson and Johnson $1 Billion for COVID-19 Vaccine
The drug maker is to deliver 100 million doses of a COVID-19 vaccineActualités similaires
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
